← Back to Search

Behavioral Intervention

Delayed Feedback for Parkinson's Disease

East Hanover, NJ
N/A
Recruiting
Led By Ekaterina Dobryakova, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Only participants with scores above 24/30 on the Montreal Cognitive Assessment will be recruited for participation to exclude dementia.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing lasts 60 minutes and completed in 1 day
Awards & highlights
No Placebo-Only Group

Summary

"This trial investigates how individuals with Parkinson's Disease learn from feedback. The study suggests that learning through delayed feedback, as opposed to immediate feedback, may lead to better learning outcomes for individuals with Parkinson's Disease

See full description
Who is the study for?
This trial is for individuals with Parkinson's Disease who can learn and remember well enough to score above 24/30 on a cognitive test called the Montreal Cognitive Assessment, which ensures they do not have dementia.Check my eligibility
What is being tested?
The study tests if people with Parkinson's Disease learn better when feedback is delayed. Participants take a multiple-choice test and receive feedback either immediately or after a 25-minute delay to see which method improves learning more.See study design
What are the potential side effects?
Since this trial involves only delayed feedback during a learning task, there are no direct medical side effects associated with the intervention being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
* Only participants with scores above 24/30 on the Montreal Cognitive Assessment will be recruited for participation to exclude dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing lasts 60 minutes and completed in 1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and testing lasts 60 minutes and completed in 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent correct responses will be collected through the computer software

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Parkinson DiseaseExperimental Treatment1 Intervention
Participants with Parkinson Disease; Single group.

Find a Location

Closest Location:Kessler Foundation· East Hanover, NJ· 720 miles
Image of Kessler Foundation in East Hanover, United States.Image of Kessler Foundation in East Hanover, United States.Image of Kessler Foundation in East Hanover, United States.

Who is running the clinical trial?

Kessler FoundationLead Sponsor
187 Previous Clinical Trials
11,156 Total Patients Enrolled
Ekaterina Dobryakova, PhDPrincipal InvestigatorKessler Foundation
~8 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top